Age-related macular degeneration (AMD) is a progressive blinding disease and represents
the leading cause of visual impairment in the aging population. AMD affects central vision …

Age-related macular degeneration is the main cause of irreversible vision in developed
countries, and intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are …

Background and Objectives: To assess the association between the single nucleotide
polymorphisms (SNPs) in the genes encoding complement factors CFH, C2, and C3 (Y402H …

Age‐related macular degeneration (AMD) is the most prevalent cause of irreversible vision
loss in industrialized countries. Several studies have investigated systemic interleukin‐6 (IL …

Precision medicine aims to improve patient care by adjusting medication to each patient's
individual needs. Age-related macular degeneration (AMD) is a heterogeneous eye disease …

Our study aimed to reveal the associations between VEGFA SNPs (rs1570360, rs699947,
rs3025033, and rs2146323), their haplotypes, VEGF-A and VEGF-R2 serum concentrations …

Aim: Evidence of the relationship between the polymorphism of the complement factor H
(CFH) gene at position 402 (Y402H) and the response to the treatment of wet AMD is …

The aim of this review is to reveal Turkey's current status of medical practice in inherited eye
diseases and the necessary steps to improve healthcare services and research activities in …

Introduction: Anti-vascular endothelial growth factor (anti-VEGF) agents have a variable
effect on patients with age-related macular degeneration (AMD) that has been attributed to …

Aortic stiffness and systemic inflammation are predictors of cardiovascular risk. Anti-vascular
endothelial growth factor agents (anti-VEGF), injected intravitreally, can reverse the course …